Please Wait a Moment
X

Articles

07Aug

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- August 8th Update

07 Aug, 2018 | Return|

CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.

Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications

Related

CTS conversion to the Ortho VERSEIA Integrated Processor (VIP) in January 2021

After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...

Read More >

Reminder-Confirmatory Algorithm and Assay Changes Effective September 30, 2019

On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...

Read More >

Notification of Form Revisions to Implement on September 2, 2019

The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...

Read More >

CTS Testing Algorithm to be Revised on December 17, 2018

The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...

Read More >

Seasonal Monitoring for WNV to begin June 1, 2020

Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...

Read More >

Creative Testing Solutions and Grifols Forge New Testing Partnership

Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...

Read More >